Department of Ophthalmology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Department of Ophthalmology, Maastricht University Medical Center+, Maastricht, The Netherlands; and.
Cornea. 2020 Nov;39(11):1463-1472. doi: 10.1097/ICO.0000000000002412.
To investigate the effect and potential predictors of corneal transplantation on patient-reported outcomes such as quality of life, visual functioning, and mental health by systematically reviewing the literature.
Studies with 1 preoperative and at least 1 postoperative measurement were searched for in relevant literature databases. Methodological quality was assessed using the Quality Assessment Tool for Quantitative Studies, and effect sizes were calculated.
Of 1445 unique publications, 14 studies, including 15 study designs, were described in 16 publications. Four randomized controlled trials, 1 controlled clinical trial, 1 cohort study, and 1 before-after study (BA) were of good quality; 6 BAs were of moderate quality; and 2 BAs were of weak quality. Patients generally improved 12 months after transplantation on health-related quality of life (effect size between 0.08 and -3.06), vision-related quality of life (-0.67 and -6.65), visual functioning (-0.55 and -0.63), and subjective visual symptoms (-0.31 and -0.86). Patient satisfaction was high (-0.95). Patients improved on depression (-0.31) but remained stable on anxiety (-0.05) 4 months after transplantation. Predictors of positive outcomes were lower preoperative visual acuity and visual functioning, better postoperative visual factors, younger age, and male sex.
Corneal transplantation showed overall beneficial effects on patient-reported outcomes. Knowledge of these effects and predictors might result in better treatment, more patient-centered care, and more realistic expectations on the part of patients and ophthalmologists. Future studies should focus on not only health- and vision-related quality of life but also mental health and labor participation using longitudinal study designs.
通过系统综述研究文献,探讨角膜移植对患者报告的结局(如生活质量、视觉功能和心理健康)的影响及其潜在预测因素。
在相关文献数据库中搜索具有 1 个术前和至少 1 个术后测量值的研究。使用定量研究质量评估工具评估方法学质量,并计算效应大小。
在 1445 篇独特的文献中,有 14 项研究(包括 15 种研究设计)在 16 篇文献中进行了描述。其中 4 项随机对照试验、1 项对照临床试验、1 项队列研究和 1 项前后研究(BA)为高质量;6 项 BA 为中质量;2 项 BA 为低质量。患者在移植后 12 个月一般在健康相关生活质量(效应大小为 0.08 至-3.06)、视觉相关生活质量(-0.67 至-6.65)、视觉功能(-0.55 至-0.63)和主观视觉症状(-0.31 至-0.86)方面有所改善。患者满意度较高(-0.95)。移植后 4 个月,患者的抑郁情况有所改善(-0.31),但焦虑情况保持稳定(-0.05)。阳性结果的预测因素为术前较低的视力和视觉功能、术后较好的视觉因素、较年轻的年龄和男性性别。
角膜移植对患者报告的结局总体上具有有益的影响。了解这些影响和预测因素可能会导致更好的治疗、更以患者为中心的护理以及患者和眼科医生更现实的期望。未来的研究应不仅关注健康和视觉相关的生活质量,还应关注心理健康和劳动参与情况,并采用纵向研究设计。